Zhang, Chao
Chen, Hua-Fei
Yan, Shi
Wu, Lin
Yan, Li-Xu
Yan, Xiao-Long https://orcid.org/0000-0003-2419-9707
Yue, Dong-Sheng
Xu, Chun-Wei
Zheng, Min
Li, Ji-Sheng
Liu, Si-Yang https://orcid.org/0000-0002-5105-6421
Yang, Ling-Ling
Jiang, Ben-Yuan
Ou, Qiu-Xiang
Qiu, Zhen-Bin https://orcid.org/0000-0003-4106-4011
Shao, Yang
Wu, Yi-Long https://orcid.org/0000-0002-3611-0258
Zhong, Wen-Zhao https://orcid.org/0000-0002-8917-8635
Funding for this research was provided by:
National Natural Science Foundation of China (81872510)
High-level Hospital Construction Project
Article History
Received: 23 January 2022
Accepted: 20 July 2022
First Online: 19 September 2022
Competing interests
: W.-Z.Z. received speech honoraria from AstraZeneca, Roche, Eli Lilly, and Pfizer. Y.-L.W. received research funding from Roche and speech honoraria from AstraZeneca, Roche, Eli Lilly, Pfizer and Sanofi, and he was a research consultant for AstraZeneca. L.W. and D.S.Y. received speech honoraria from AstraZeneca and Roche. L.-L.Y., Q.-X.O., and Y.S. are employees of Nanjing Geneseeq Technology Inc. The remaining authors declare no conflict of interest.